Clene Inc. (CLNN) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Clene reported revenue of $200,000, down 41.5% from $342,000 the year before. Net income was -$26.2M (a -13086.5% net margin). Gross margin was 78.5% and operating margin was -11541.5%. Operating activities generated -$18.5M of cash, leaving -$18.5M of free cash flow. At fiscal year end, Clene held $18.1M in total assets against $35.7M in total liabilities, including $5.2M of cash and equivalents.
Open the full interactive Clene financials → Quarterly statements, key ratios, valuation history and price charts.
Clene Key Stats
| Share Price | $3.39 |
|---|---|
| Market Cap | $42.0M |
| Revenue YoY Growth | -41.5% |
| 52-Week Range | $3.28 – $12.50 |
| Shares Outstanding | 12.4 million (basic, 2026 Q2) |
Clene Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $206,000 | $723,000 | $473,000 | $654,000 | $342,000 | $200,000 |
| Cost of Goods Sold | — | — | $48.9M | $41.2M | $33.4M | $23.3M |
| Gross Profit | — | — | $447,000 | $533,000 | $272,000 | $157,000 |
| Operating Income | -$20.2M | -$50.0M | -$48.4M | -$40.5M | -$33.1M | -$23.1M |
| Pre-Tax Income | -$18.9M | -$10.2M | -$29.9M | -$49.5M | -$39.4M | -$26.2M |
| Income Tax | $406,000 | -$428,000 | $0 | $0 | $0 | $0 |
| Net Income | -$19.3M | -$9.7M | -$29.9M | -$49.5M | -$39.4M | -$26.2M |
| Diluted EPS | -$22.00 | -$3.20 | — | — | — | — |
Clene Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $15,000 | $77,000 | $15,000 | $90,000 |
| Net Income | -$8.8M | -$9.2M | -$8.1M | -$13.4M |
Clene Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $59.3M | $50.3M | $18.3M | $28.8M | $12.2M | $5.2M |
| Current Assets | $63.0M | $54.6M | $29.2M | $38.9M | $16.2M | $9.0M |
| Total Assets | $68.2M | $63.1M | $44.5M | $52.3M | $27.3M | $18.1M |
| Current Liabilities | $11.7M | $6.0M | $13.9M | $25.3M | $10.3M | $10.8M |
| Total Long-Term Debt | $7.9M | $14.5M | $15.9M | $16.5M | $15.8M | $17.8M |
| Total Liabilities | $67.9M | $50.5M | $41.3M | $39.0M | $36.2M | $35.7M |
| Shareholders' Equity | $341,000 | $12.6M | $3.2M | $13.4M | -$8.9M | -$17.6M |
Clene Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$18.9M | -$34.6M | -$39.0M | -$30.2M | -$21.3M | -$18.5M |
| Cash From Investing | -$387,000 | -$1.3M | -$10.2M | -$1.5M | $6.3M | -$39,000 |
| Cash From Financing | $69.5M | $27.1M | $17.2M | $42.2M | -$1.5M | $11.5M |
| Free Cash Flow | $18.5M | -$35.9M | -$44.2M | -$30.5M | -$21.3M | -$18.5M |
Figures from Clene's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Clene financials page for every line item.
Clene Company Profile
| Ticker | CLNN |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Salt Lake City, Utah |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001822791 |
Frequently Asked Questions
What was Clene's revenue in fiscal 2025?
Clene (CLNN) reported revenue of $200,000 for fiscal 2025.
What is Clene's annual revenue history?
Clene's annual revenue by fiscal year: 2020: $206,000; 2021: $723,000; 2022: $473,000; 2023: $654,000; 2024: $342,000; 2025: $200,000.
What was Clene's net income in fiscal 2025?
Clene reported net income of -$26.2M for fiscal 2025.
How much free cash flow did Clene generate in fiscal 2025?
Clene generated -$18.5M of free cash flow in fiscal 2025.
What was Clene's revenue last quarter?
In its most recent reported quarter (2026 Q2), Clene reported revenue of $90,000.
How much debt does Clene have?
Clene reported $17.8M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Clene are outstanding?
Clene reported a weighted average of 12.4 million basic shares outstanding in 2026 Q2.
What is Clene's market cap?
Based on its latest closing price, Clene (CLNN) has a market capitalization of about $42.0M.
When does Clene's fiscal year end?
Clene's fiscal year end, as registered with the SEC, is December 31.
Where is Clene headquartered?
Clene lists its business address in Salt Lake City, Utah in its SEC filings.